CytoSorbents to join virtual chat with D. Boral Capital on Dec 15, 2025. Leaders to discuss blood purification treatment. CEO Dr. Phillip Chan and CFO Peter J. Mariani to participate.
In Princeton, New Jersey, on December 10, 2025, CytoSorbents Corporation (NASDAQ: CTSO), known for its expertise in treating critical conditions in the ICU and during cardiac surgery through blood purification, revealed that its CEO, Dr. Phillip Chan, and CFO, Peter J. Mariani,....
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments